Your browser doesn't support javascript.
loading
Sustainable asymmetric synthesis of diltiazem precursor enabled by recombinant Escherichia coli whole cells co-expressing an engineered ketoreductase and glucose dehydrogenase.
Yue, Xiaoping; Li, Yitong; Yang, Lin; Sang, Di; Huang, Zedu; Chen, Fener.
Afiliação
  • Yue X; Engineering Center of Catalysis and Synthesis for Chiral Molecules, Department of Chemistry, Fudan University, Shanghai, P. R. China.
  • Li Y; Shanghai Engineering Research Center of Industrial Asymmetric Catalysis of Chiral Drugs, Shanghai, P. R. China.
  • Yang L; Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu, P. R. China.
  • Sang D; Engineering Center of Catalysis and Synthesis for Chiral Molecules, Department of Chemistry, Fudan University, Shanghai, P. R. China.
  • Huang Z; Shanghai Engineering Research Center of Industrial Asymmetric Catalysis of Chiral Drugs, Shanghai, P. R. China.
  • Chen F; Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu, P. R. China.
Biotechnol J ; 19(1): e2300250, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38048389

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diltiazem / Glucose 1-Desidrogenase Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diltiazem / Glucose 1-Desidrogenase Idioma: En Ano de publicação: 2024 Tipo de documento: Article